References
Kovacs GG, Wagner U, Dumont B et al (2012) An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology. Acta Neuropathol 124:37–50. doi:10.1007/s00401-012-0964-x
Laske C, Fallgatter AJ, Stransky E et al (2011) Decreased α-synuclein serum levels in patients with Lewy body dementia compared to Alzheimer’s disease patients and control subjects. Dement Geriatr Cogn Disord 31:413–416. doi:10.1159/000329763
Malek N, Swallow D, Grosset KA et al (2014) Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson’s disease—a systematic review. Acta Neurol Scand. doi:10.1111/ane.12247
Mollenhauer B, Locascio JJ, Schulz-Schaeffer W et al (2011) α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10:230–240. doi:10.1016/S1474-4422(11)70014-X
Parnetti L, Castrioto A, Chiasserini D et al (2013) Cerebrospinal fluid biomarkers in Parkinson disease. Nat Rev Neurol 9:131–140. doi:10.1038/nrneurol.2013.10
Shi M, Zabetian CP, Hancock AM et al (2010) Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson’s disease. Neurosci Lett 480:78–82. doi:10.1016/j.neulet.2010.06.009
Unterberger U, Lachmann I, Voigtländer T et al (2014) Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study. Clin Neuropathol 33:329–334
Acknowledgments
We thank Ron Postuma for comments to the manuscript. The study has been partly supported by the BIOMARKAPD project (JPND Research). Samples were obtained from the Neuro-Biobank of the University of Tuebingen, Germany (http://www.hih-tuebingen.de/core-facilities/biobank/for-researchers/). This biobank is supported by the local University, the Hertie Institute and the DZNE.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
W. Maetzler, A. Pilotto and A. Apel equally contributed to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Maetzler, W., Pilotto, A., Apel, A. et al. In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody. Acta Neuropathol 128, 893–895 (2014). https://doi.org/10.1007/s00401-014-1364-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-014-1364-1